Articles by Amy Ritter - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Amy Ritter

FTC Reports an Increase in Anticompetitive Activities Among Drug Makers

Jan 22, 2013

According to the Federal Trade Commission, the number of potentially anticompetitive patent dispute settlements between branded and generic drug companies increased between 2011 and 2012.

Lonza Expands Antibody-Drug Conjugate Manufacturing Capacity

Jan 15, 2013

Lonza will invest CHF 14 million ($15.1 million) to double the existing large-scale manufacturing capacity in Visp, Switzerland.

AbbVie Celebrates Official Launch

Jan 7, 2013

AbbVie, a research-focused, specialty biopharmaceutical company that was spun off from Abbott Pharmaceuticals, was officially launched on Jan. 2, 2013

Amgen Settles False Claims Act Allegations

Dec 27, 2012

Amgen has agreed to pay $762 million to resolve criminal liability and false claims act allegations.

FDA Approves First Anthrax Antitoxin

Dec 24, 2012

Anthrax antitoxin is the first monoclonal antibody approved under FDA's Animal Efficacy Rule, and the first product from BARDA's Project Bioshield to receive FDA approval.

Pfizer Settles Off-Label Promotion Charges

Dec 17, 2012

Pfizer has agreed to pay USD 55 million plus interest to settle charges that Wyeth (acquired by Pfizer in October 2009) improperly promoted the drug Protonix (pantoprazole).

Biogen Idec and Isis Pharmaceuticals to Collaborate on Antisense Programs

Dec 10, 2012

Biogen Idec and Isis Pharmaceuticals announced that they have entered into a global collaboration agreement to discover and develop antisense drugs against three undisclosed targets to treat neurological or neuromuscular disorders.

Lilly Releases Corporate Responsibility Update

Dec 3, 2012

Eli Lilly released its annual report containing updates on progress and new initiatives in corporate responsibility.

Job Security

Annual employment survey results show greater confidence in the pharma industry.
Dec 2, 2012

Annual employment survey results show greater confidence in the pharma industry.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here